What is AngioDynamics's D&A?

AngioDynamics (ANGO) reported D&A of $5.59M in Q4 2025.

How has AngioDynamics's D&A changed year-over-year?

AngioDynamics's D&A decreased by 11.5% year-over-year, from $6.32M to $5.59M.

What is the long-term trend for AngioDynamics's D&A?

Over 4 years (2021 to 2025), AngioDynamics's D&A has grown at a -0.1% compound annual growth rate (CAGR), from $25.92M to $25.8M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

AngioDynamics ANGO D&A

D&A at other companies

Becton, Dickinson and CompanyBDX

$563M-0.7%

TFX

TeleflexTFX

$19.85M+52.3%

Merit Medical SystemsMMSI

$30.5M+4.1%

ICU MedicalICUI

$50.03M+1.2%

Boston ScientificBSX

$351M+8.0%

PenumbraPEN

$4.57M-8.8%

Other financials

Income statement

See full

Revenue$78.4M+8.9%

Gross profit$41.5M+6.7%

Operating income-$13.0M-29.8%

Net income-$8.1M-83.4%

EPS (diluted)-$0.19-72.7%

Balance sheet

See full

Cash & equivalents$37.8M-15.5%

Total debt$7.9M+10.2%

Total equity$173.4M-6.7%

Total assets$260.7M-8.7%

Cash flow

See full

Operating cash flow-$3.1M+76.4%

CapEx$1.0M-43.5%

Free cash flow-$4.1M+72.4%

Valuation

See full

Market cap$564.42M+38.7%

Enterprise value$534.51M+48.0%

P/S1.8×+0.4×

Profitability

See full

Gross margin54.3%-0.1pp

Operating margin-11.3%-2.9pp

Net margin-10%-2.4pp

FCF margin5.5%—

Returns & leverage

See full

Return on equity-17.5%-2.2pp

Debt / equity0×0.0×

Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AngioDynamics's D&A?: AngioDynamics (ANGO) reported D&A of $5.59M in Q4 2025.
How has AngioDynamics's D&A changed year-over-year?: AngioDynamics's D&A decreased by 11.5% year-over-year, from $6.32M to $5.59M.
What is the long-term trend for AngioDynamics's D&A?: Over 4 years (2021 to 2025), AngioDynamics's D&A has grown at a -0.1% compound annual growth rate (CAGR), from $25.92M to $25.8M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.